Commercial insurance delays direct-acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Commercial insurance delays direct-acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients'. Together they form a unique fingerprint.

Medicine & Life Sciences